ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association Between Metabolic Dysfunction- Associated Fatty Liver Disease and the Risk of Cirrhosis in Patients with Chronic Hepatitis B-A Retrospective Cohort Study

Wang, Qing-Xia; Xue, Jiao; Shi, Mei-Jie; Xie, Yu-Bao; Xiao, Huan-Ming; Li, Sheng; Lin, Ming; Chi, Xiao-Ling*广东省人民医院; 广州中医药大学
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy2022DOI: 10.2147/DMSO.S369824
6被引6阅读
引用收藏
分享

摘要

Background: Metabolic dysfunction-associated fatty liver disease (MAFLD) is a novel proposed concept that is being recognized worldwide. Both chronic hepatitis B (CHB) and MAFLD have been independently attributed to an increased risk of disease development to cirrhosis. However, it is still unclear whether MAFLD is associated with an increased risk of cirrhosis in CHB patients. Aim: This study aimed to analyze the impact of MAFLD on the risk of cirrhosis in CHB patients. Methods: In this retrospective cohort study, consecutive CHB patients with or without MAFLD were enrolled from January 1st, 2007, to May 1st, 2020, in Guangdong Provincial Hospital of Chinese Medicine. Inverse probability treatment weighting (IPTW) was performed to balance the covariates across groups. The weighted Kaplan-Meier analysis and Cox regression analysis were used to compare both groups for the risk of cirrhosis. Results: A total of 1223 CHB patients were included in this study during the median follow-up of 5.25 years; of these patients, 355 were CHB-MAFLD patients. After IPTW, the weighted Kaplan-Meier analysis showed that the weighted cumulative incidence of cirrhosis was significantly higher in patients with MAFLD than that in patients without MAFLD (12.6% versus 7.1%, P=0.015). In the weighted multivariate Cox analysis, coexisting MAFLD was related to an increased risk of cirrhosis [adjusted weighted hazard ratio (HR) 1.790; P =0.020]. Age (> 40 years, adjusted weighted HR, 1.950; P=0.015), diabetes mellitus (adjusted weighted HR, 1.883; P=0.041), non-antiviral treatment (adjusted weighted HR, 2.037; P=0.013), and baseline serum HBV DNA levels (> 2.4 log10 IU/mL, adjusted weighted HR, 1.756; P=0.045) were significant risk factors for cirrhosis. Conclusion: We found that MAFLD was associated with a higher risk of cirrhosis in CHB patients.

学科与关键词

关键词
chronic hepatitis Bmetabolic dysfunction-associated fatty liver diseasehepatic steatosiscirrhosis
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
发表日期
2022
卷期
第 15 卷
页码
2311-2322
DOI
10.2147/DMSO.S369824
期刊等级
4区
成果收录
SCIE
资助标注
Thirteen Five -Year Plan for Major and Special Program of the National Science and Technology of China [2018ZX10725506-003, 2018ZX10725505-004]; Guangdong Provincial Hospital of Chinese Medicine [YN2016XP03]; Clinical research projects of Guangdong Provincial Hospital of Chinese Medicine [YN10101903]; Science and Technology research project of Traditional Chinese Medicine of Guangdong Provincial Hospital of Chinese Medicine [YN2021DB07]

作者

  • W

    Wang, Qing-Xia (第一作者)

    2 · guangzhou univ chinese med

  • X

    Xue, Jiao

    2 · guangzhou univ chinese med

查看全部 8 位作者收起作者
  • S

    Shi, Mei-Jie

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xie, Yu-Bao

    2 · guangdong prov hosp · guangzhou univ chinese med

  • X

    Xiao, Huan-Ming

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Li, Sheng

    2 · guangdong prov hosp · guangzhou univ chinese med

  • L

    Lin, Ming

    2 · guangdong prov hosp · guangzhou univ chinese med

  • C

    Chi, Xiao-Ling (通讯)

    2 · guangdong prov hosp · guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417